--- title: "The She-conomy: Why Women's Health is the Next Trillion-Dollar Frontier | Hypergility" description: "De-risking the future of women's health tech: moving beyond the what of a product to master the why of user adoption in a trillion-dollar emerging market." lang: en json-ld: | { "@context": "https://schema.org", "@type": "BlogPosting", "headline": "The She-conomy: Why Women's Health is the Next Trillion-Dollar Frontier", "description": "De-risking the future of women's health tech: moving beyond the what of a product to master the why of user adoption in a trillion-dollar emerging market.", "author": [ { "@type": "Person", "name": "Ness Daly", "jobTitle": "Alumna — Signal Equity collaborator", "url": "https://www.hypergility.com/team/ness-daly" } ], "datePublished": "2026-02-26T11:00:00+00:00", "dateModified": "2026-05-21T16:28:51.808646+00:00", "image": "https://aaiqevwzojrlzhxdxxzq.supabase.co/storage/v1/object/public/media-processed/blog-heroes/the-she-conomy-why-women-s-health-is-the-next-trillion-dollar-frontier.jpg", "keywords": "For founders", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.hypergility.com/blog/the-she-conomy-why-women-s-health-is-the-next-trillion-dollar-frontier" }, "citation": [ { "@type": "CreativeWork", "name": "McKinsey Health Institute — Closing the Women's Health Gap (Jan 2024)", "url": "https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies" }, { "@type": "CreativeWork", "name": "FemTech Analytics — UK FemTech Landscape 2026", "url": "https://www.femtech.health/" }, { "@type": "CreativeWork", "name": "BVCA — UK Venture Capital Activity Report H1 2026", "url": "https://www.bvca.co.uk/Research/BVCA-Publications" } ], "publisher": { "@type": "Organization", "name": "Hypergility", "url": "https://www.hypergility.com" } } --- [![Hypergility](/assets/hypergility-logo-BKOgRT51.png)for bold startups ](/) Services [Startup Grower](https://startupgrower.hypergility.io/)[Website Build](/build-your-website)[Public Sector Bids](/offerings/win-public-sector-bids)[Management Systems & Assurance](/services/management-systems) Who it's for [Are you a bold founder?](/are-you-a-bold-founder)[Innovation Hubs](/partners/innovation-hubs)[Universities](/partners/universities)[Researchers](/personas/researchers) [Why us](/why-us)[News](/news)[Try Startup Grower](https://startupgrower.hypergility.io/)[Contact](/contact) [Back to News](/news) ![The She-conomy: Why Women's Health is the Next Trillion-Dollar Frontier](https://aaiqevwzojrlzhxdxxzq.supabase.co/storage/v1/object/public/media-processed/blog-heroes/the-she-conomy-why-women-s-health-is-the-next-trillion-dollar-frontier.jpg) For founders # The She-conomy: Why Women's Health is the Next Trillion-Dollar Frontier Ness Daly February 26, 2026 TL;DR - The women's health gap is a $1T/yr global GDP opportunity by 2040 (McKinsey, Jan 2024). - Specialisation wins — single-condition products beat 'general wellness' apps every time. - Community-first marketing + clinical-grade evidence = trust that compounds into retention. - User research and behavioural science are an unfair advantage in a taboo-laden category. - Off-the-shelf LLMs carry the gender data gap — purpose-trained models are now a defensible USP. Mid-2026 update: The thesis has only sharpened in 2026. McKinsey's January 2024 'Closing the Women's Health Gap' analysis still anchors the number — closing the gap could add $1 trillion to global GDP annually by 2040 — and H1 2026 has seen a wave of UK women's-health raises (Elvie, Peppy, Hertility) that confirm investor appetite is structural, not cyclical. The blueprint below is what's working right now. If you ever needed proof that passion and purpose are the most powerful fuels for innovation, the recent panel I attended on the future of women's health provided it in spades. The conversation wasn't just about medicine; it was about justice, data, and a multi-billion-dollar opportunity hiding in plain sight. On Tuesday I went to an event in Central London hosted by Covington & Burling LLP and Nexus – a new app for women's health tracking. The panel brought together a formidable group: a pharmaceutical expert driven by her brother's epilepsy, a VC founder who traded her therapy practice for a $70 million "Revenge" fund, a tech founder motivated by his wife's and sister's diagnostic odysseys, a life sciences lawyer, and a researcher at the forefront of health AI. Their personal stories illuminated a systemic failure. As one speaker starkly put it, the healthcare system—from clinical trials to AI algorithms—has been built on a default male model. The consequences are not just inconvenient; they are life-threatening. ### The Invisible Patient: How We Got Here The history is as shocking as it is recent. As one expert detailed, following the thalidomide disaster in the 1970s, the FDA essentially banned women of "childbearing potential" from clinical trials for nearly two decades. The assumption was that women were simply smaller men, and drug responses would be the same. This bias is baked into our foundational medical data. This legacy persists today: - Misdiagnosis: Women are more likely to be dismissed as "stressed" or "anxious" when presenting with symptoms, a phenomenon known as the "Yentl Syndrome." - Glaring Inequity: Conditions like endometriosis and PCOS are severely under-researched and underfunded compared to male conditions like erectile dysfunction. - Data Void: The very algorithms powering new health tech, including consumer tools like ChatGPT, are trained on this biased data, perpetuating the cycle of neglect. ### Driving UK Startup Growth by Bridging the Gap For UK startups, this isn't just a social imperative; it's the clearest growth map you could ask for. The insights from the panel point to three powerful strategies for innovation and scaling. > “Women's health isn't a vertical — it's a missing operating system. The founders who treat it that way are the ones VCs are writing cheques to in 2026.” — Alicia Crowther , Hypergility #### 1\. Go Deep, Not Just Broad: The Specialisation Advantage The biggest mistake a startup can make in this space is trying to be everything to every woman. The problems are too nuanced. The successful companies identified by the panel are hyper-specialised: - Cyclonica: Diagnosing endometriosis using menstrual fluid. - Pexxi: A supplement specifically formulated for period pain. - Ditto: Tackling postnatal care with a blended digital and physical model. **The Growth Lesson:** Don't build another general wellness app. Identify a single, specific, and underserved condition—like incontinence, menopause-related frozen shoulder, or postnatal recovery—and own it completely. Depth beats breadth when you're correcting for decades of neglect. #### 2\. Build Trust by Building Community and Clinical Rigour A powerful question from the audience highlighted a critical challenge: how do you reach women who are distrustful of the healthcare system? The answer lies in community and evidence. - Community as a Channel: Trust often lies with local charities, religious groups, and grassroots organisations, not with large institutions. Startups that partner with these trusted entities can build credibility and reach "hard-to-reach" users authentically. - Clinical Rigour as a Moat: Robust data is your differentiator. Utilise the UK's innovation grants to fund proper clinical trials before you seek major venture funding. **The Growth Lesson:** Your marketing strategy should be community-first, and your product strategy should be evidence-first. This builds a loyal user base and a defensible market position that investors will fight to back. #### 3\. Master the "Why": The Unfair Advantage of User Research & Behavioural Science A great medical solution can fail if it doesn't account for the real-world user. This is where deep user research and behavioural science become a startup's unfair advantage. Women's health is fraught with taboos, fatigue from the "care cycle," and complex daily routines. Simply providing information is not enough. Startups must ask: - What are the unspoken barriers? Is it shame? Is it time poverty? Is it a lifetime of being dismissed that has led to a "why bother?" attitude? - How can we design for action? Can you use nudges to help a sleep-deprived new mother remember her supplements? Can you use gamification to make tracking symptoms feel empowering rather than burdensome? **The Growth Lesson:** Integrate user researchers and behavioural scientists from day one. By understanding the emotional and behavioural context of your users, you can design products that people not only need but will actually use and love. #### 4\. Turn the AI Bias into Your USP The discussion on AI was a wake-up call. Off-the-shelf large language models (LLMs) are riddled with the gender data gap, often "hallucinating" or providing biased responses when asked about women's health. One start-up tackled this not by using a generic AI, but by building its own from the ground up. They trained their model on a proprietary corpus of peer-reviewed women's health research and user data, ensuring both accuracy and privacy. **The Growth Lesson:** Don't just use AI; build your AI. In a world of biased algorithms, a specialised, accurately trained model isn't just a feature—it's your entire unique selling proposition (USP). ### A Call to Action: The Power of the Ecosystem The final, crucial insight was about allyship. The room, though passionate, needed more men. The growth of the UK's women's health ecosystem depends on this. It requires: - Founders to specialise, validate, and deeply understand their users' behaviours. - Investors to look beyond conventional sectors, fund with conviction, and value behavioural insights as a key metric for success. - Consumers to support and champion these new solutions. - Allies to amplify the conversation and demand change. The UK has the talent, the research institutions, and a growing sense of urgency. The blueprint for innovation is clear. It's time to stop building for a world that doesn't exist and start innovating for the one that does—a world where women's health is not an afterthought, but the cornerstone of a healthier, and more prosperous, society for all. #### An Afterthought: The Coder's Bias As we build this new future, there's a foundational layer we cannot ignore: who is writing the code? The AI bias problem isn't just about the data going in; it's also about the perspectives of the architects building the systems. Algorithms are not neutral. They are shaped by the assumptions, experiences, and blind spots of their creators. When a discipline is homogenous—as tech and coding have historically been—those blind spots become embedded in the technology itself. Bringing more women into software engineering, data science, and AI development isn't just a diversity initiative; it's a critical step in the quality assurance process. It is a fundamental method for debugging bias at the source. By diversifying the teams that build our technological future, we don't just create fairer algorithms for women's health; we build smarter, more robust, and more accurate systems for everyone. Grower is Hypergility's AI co-founder for early-stage teams — turning strategy into traction, week after week. [Try Grower](https://startupgrower.hypergility.io) ## Sources 1. [McKinsey Health Institute — Closing the Women's Health Gap (Jan 2024)](https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies) 2. [FemTech Analytics — UK FemTech Landscape 2026](https://www.femtech.health/) 3. [BVCA — UK Venture Capital Activity Report H1 2026](https://www.bvca.co.uk/Research/BVCA-Publications) Trusted by clients & partners ## Clients and partners we work with [![Sussex Innovation](/trusted-logos/sussex-innovation.png)](https://www.sussexinnovation.co.uk/)[![Aqueous Digital](/trusted-logos/aqueous-digital.png)](https://www.aqueous-digital.co.uk/)[![The Growth Orchard](/trusted-logos/growth-orchard.png)](https://thegrowthorchard.co.uk/)[![GovForms](/trusted-logos/govforms.png)](https://govforms.co.uk/)[![SITA](/trusted-logos/sita.png)](https://www.sita.aero/)[![University of Sussex](/trusted-logos/university-of-sussex.png)](https://www.sussex.ac.uk/) As seen at ## Where we show up in the community [![BrightonAI Show and Tell](/trusted-logos/brightonai.png)](https://brightonai.org) Certifications ## Standards we are independently certified against [ ![ISO 9001 Badge](/assets/iso-9001-DeXtyob9.svg) ISO 9001 Quality Management ](/we-are-iso-9001-company-certified)[ ![ISO 27001 Badge](/assets/iso-27001-BiHzm-R-.svg) ISO 27001 Information Security ](/we-are-iso-27001-company-certified)[ ![ISO 42001 Badge](/assets/iso-42001-WNouqNfX.svg) ISO 42001 AI Management System ](/we-are-iso-42001-company-certified)[ Cyber Essentials UK Cyber Security ](/we-are-cyber-essentials-certified)[ Cyber Essentials Plus Independently verified ](/we-are-cyber-essentials-plus-certified) [![Hypergility](/assets/hypergility-logo-BKOgRT51.png)](/) People and our AI companion — challenging you, not just agreeing Making ideas investable For founders — we help you shape it, set it up, build it and monetise it. [Try Grower](https://startupgrower.hypergility.io/)[](https://www.linkedin.com/company/hypergility) #### Starting out Lane overviews - [Starting out](/starting-out) - [Are you a bold founder?](/are-you-a-bold-founder) - [The Startup In You](/the-startup-in-you) - [Resources in play](/resources-in-play) Stepping up - [Overview](/stepping-up) - [Researchers](/personas/researchers) - [Sales rainmakers](/personas/sales-rainmakers) - [Tech wizards](/personas/tech-wizards) - [Domain experts](/personas/domain-experts) - [Creative designers](/personas/creative-designers) - [Voluntary redundancy](/personas/voluntary-redundancy) - [Retiring, not done](/personas/retiring-not-done) No job, need a path - [Overview](/no-job-need-a-path) - [Made redundant](/personas/made-redundant) - [End of contract](/personas/end-of-contract) - [Mutually parted ways](/personas/mutually-parted-ways) - [Resigned](/personas/resigned) - [Pushed out, can't get back](/personas/pushed-out-cant-get-back) - [Overqualified / age barriers](/personas/overqualified-age-barriers) - [Returning after a break](/personas/returning-after-break) - [Retired, need income](/personas/retired-need-income) - [Never employed](/personas/never-employed) - [Grads, no offers](/personas/grads-no-offers) Fitting it in - [Overview](/fitting-it-in) - [Students / college](/personas/students) - [Side hustlers](/personas/side-hustlers) - [Work returners](/personas/work-returners) - [Career changers](/personas/career-changers) - [Family duties](/personas/family-duties) - [Health / disability barriers](/personas/health-disability-barriers) - [Post-prison](/personas/post-prison) - [Underrepresented founders](/personas/underrepresented-founders) #### Resources in play Lane overviews - [Resources](/resources) - [Roadmap](/roadmap) - [News & insights](/news) Short runway - [Overview](/short-runway) - [Cash crunch](/personas/cash-crunch) - [Turnaround / restructure](/personas/turnaround) - [Distressed](/personas/distressed) - [Preserve, or pivot](/personas/preserve-or-pivot) Resourced and reloading - [Overview](/resourced-and-reloading) - [Successful exiters](/personas/successful-exiters) - [Go-again success seekers](/personas/go-again) - [Post-raise reset](/personas/post-raise-reset) - [Pre-series A](/personas/pre-series-a) - [Grant-funded R&D](/personas/grant-funded-rd) - [Money inheritors](/personas/money-inheritors) Struggling with investors - [Overview](/struggling-with-investors) - [Pitch isn't landing](/personas/pitch-not-landing) - [Wrong room, wrong investors](/personas/wrong-room) - [Term-sheet stalled](/personas/term-sheet-stalled) - [Bridge or down-round](/personas/bridge-or-down-round) - [Post-rejection reset](/personas/post-rejection-reset) #### Startup Grower - [Grower overview](/grower) - [Validate](/grower/validate) - [Pitch](/grower/pitch) - [First customer](/grower/first-customer) - [Brand site](/grower/brand-site) - [Open Grower app](https://startupgrower.hypergility.io/) - [Website Build](/build-your-website) - [Public Sector BidsLater ](/offerings/win-public-sector-bids) - [All offerings](/all-offerings) - [Pricing](/pricing) - [Roadmap](/roadmap) #### Capabilities - [AI safety](/ai-safety) - [R&D claims](/rnd-claims) - [Smarter IP](/smarter-ip) - [Trust & certifications](/trust) #### Company - [Privacy](/privacy-policy) - [Cookies](/cookie-policy) - [Terms](/terms-of-use) - [Use policy](/use-policy) - [ICO registration](/ico-registration) - [AI ethics](/ai-ethics) - [IP statement](/ip-statement) - [Image attribution](/image-attribution) #### Company - [Home](/) - [What we do](/what-we-do) - [Why us](/why-us) - [Contact](/contact) - [News](/news) - [Roadmap](/roadmap) - [Sitemap](/sitemap) - [llms.txt](/llms.txt) - [Trust & certifications](/trust) #### How we work [ Do it yourself Self-serve with Grower ](/do-it-yourself)[ Do it with you Coaching & expert sprints ](/do-it-with-you)[ Do it for you Done-for-you delivery ](/do-it-for-you)[ Do it with a partner Vetted specialist network ](/do-it-with-a-partner) #### Offerings Tap any card for the dedicated page. Status shown on each. Launch sequence — earliest to latest Live shipping today — buy or book now › Next in build, launching soon › Later scheduled, design stage › On radar validated demand, no date yet [Shape](/shape) Pressure-test the idea - [Is my idea any good?Live ](/offerings/is-my-idea-any-good) - [Bootstrap your runwayLive ](/offerings/bootstrap-your-runway) - [Validate fastLive ](/offerings/validate-fast) - [Size the prizeNext ](/offerings/size-the-prize) - [Competitor intelligenceNext ](/offerings/competitor-intelligence) - [Nail the pitchLive ](/offerings/nail-the-pitch) [Set-up](/set-up) Get the foundations right - [Incorporate & structureLive ](/offerings/incorporate-and-structure) - [Cap table & equityNext ](/offerings/cap-table-and-equity) - [Tax-efficient share schemesOn radar ](/offerings/tax-efficient-share-schemes) - [Claim R&D creditsLive ](/offerings/claim-randd-credits) - [SEIS/EIS advance assuranceLater ](/offerings/seis-eis-advance-assurance) - [Signal EquityNext ](/offerings/signal-equity) [Build](/build) Ship what customers want - [Ship the productLater ](/offerings/ship-the-product) - [Get found onlineNext ](/offerings/get-found-online) - [Win grants & innovation loansLater ](/offerings/win-grants-and-innovation-loans) [Monetise](/monetise) Turn traction into revenue - [Win first customersNext ](/offerings/win-first-customers) - [Pricing & business modelNext ](/offerings/pricing-and-business-model) - [Buyer-ready sales decksNext ](/offerings/buyer-ready-sales-decks) - [Activate IP for partnershipsLive ](/offerings/activate-ip-for-partnerships) - [Win public sector bidsLater ](/offerings/win-public-sector-bids) - [C-suite distribution networkOn radar ](/offerings/c-suite-distribution-network) #### Partner network Advisors & Professionals - [Accountants & advisors](/partners/accountants) - [Lawyers & legal advisors](/partners/lawyers) - [Agencies & consultants](/partners/agencies-and-consultants) - [Independent consultants](/for-consultants) Capital & Community - [Investors, angels & syndicates](/partners/investors) - [Founder communities & networks](/partners/communities) - [Trade associations](/partners/trade-associations) Innovation & Education - [Universities & TTOs](/partners/universities) - [Innovation hubs & incubators](/partners/innovation-hubs) - [Accelerators](/partners/accelerators) - [Tech & integration partners](/partners/tech-and-integration-partners) Workforce Transitions - [Outplacement agencies](/for-outplacement-agencies) - [HR & redundancy teams](/for-employers-redundancy) #### Registered Hypergility Hypergility Ltd & Hypergility Innovations Ltd [help@hypergility.com](mailto:help@hypergility.com) Trading address Science Park Square Brighton BN1 9SB Registered office 66 Paul Street London England EC2A 4NA #### Independently certified [![ISO 9001](/assets/iso-9001-DeXtyob9.svg)ISO 9001 ](/we-are-iso-9001-company-certified "ISO 9001")[![ISO 27001](/assets/iso-27001-BiHzm-R-.svg)ISO 27001 ](/we-are-iso-27001-company-certified "ISO 27001")[![ISO 42001](/assets/iso-42001-WNouqNfX.svg)ISO 42001 ](/we-are-iso-42001-company-certified "ISO 42001")[CE Cyber Essentials ](/we-are-cyber-essentials-certified "Cyber Essentials")[CE+ Cyber Essentials Plus ](/we-are-cyber-essentials-plus-certified "Cyber Essentials Plus") © 2016 - 2026 Hypergility Ltd. All rights reserved. © 2024 - 2026 Hypergility Innovations Ltd. All rights reserved. We use cookies to improve your experience and analyse site traffic. You can manage your preferences or read our [Privacy Policy](/privacy-policy). Accept AllReject Non-EssentialManage Preferences